Cord blood cytokines are modulated by maternal farming activities and consumption of farm dairy products during pregnancy: The PASTURE Study - 12/09/11
PASTURE Study Group‡
Abstract |
Background |
Traditional farming represents a unique model situation to investigate the relationship of early-life farm-related exposure and allergy protection.
Objectives |
To investigate associations between maternal farm exposures and cytokine production in cord blood (CB) mononuclear cells in a prospective multinational birth cohort of 299 farm and 326 nonfarm children and their families.
Methods |
Supernatants from phorbol 12-myristate 13-acetate/ionomycin–stimulated CB mononuclear cells were assessed for the production of IFN-γ, TNF-⍺, IL-5, IL-10, and IL-12.
Results |
Significantly higher levels of IFN-γ and TNF-⍺ in farm compared with nonfarm children were found, whereas IL-5, IL-10, and IL-12 levels did not differ between study groups. Maternal contact with different farm animal species and barns and consumption of farm-produced butter during pregnancy enhanced the production of proinflammatory CB cytokines, whereas maternal consumption of farm-produced yogurt resulted in significant lower levels of IFN-γ and TNF-⍺ in umbilical blood.
Conclusion |
Maternal exposure to farming activities and farm dairy products during pregnancy modulated cytokine production patterns of offspring at birth.
Le texte complet de cet article est disponible en PDF.Key words : Hygiene hypothesis, allergy protection farm, effect, cord blood cytokine pattern
Abbreviations used : CB, EPS, GMR, PARSIFAL, PASTURE, PMA
Plan
Supported by the European Union (research grant QLK4-CT-2001-00250). |
|
Disclosure of potential conflict of interest: M. J. Ege received research support from grant EU FOOD-CT-2004-506378 and Deutsche Forschungsgemeinschaft. S. Krauss-Etschmann has served as an expert witness on the evaluation of health claims on probiotic products for European Food Safety Authorities. R. Lauener has received research support from the European Union and the Kuhne Foundation. J. Pekkanen has received research support from the European Union 7th Framework Programme, Finnish foundations, and the Academy of Finland. E. von Mutius has served as a consultant for GlaxoSmithKline, Union Chemique Belge (UCB), and ProtectImmun; has received research support from Airsonett; and is on the editorial board for the New England Journal of Medicine. The rest of the authors have declared that they have no conflict of interest. |
Vol 125 - N° 1
P. 108 - janvier 2010 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?